Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM-Reference-Cited by-同舟云学术

Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM

Published:2018-05-16 Issue:1 Volume:139 Page:145-152
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Rowe Lindsay S.,Butman John A.,Mackey Megan,Shih Joanna H.,Cooley-Zgela Theresa,Ning Holly,Gilbert Mark R.,Smart DeeDee K.,Camphausen Kevin,Krauze Andra V.

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/article/10.1007/s11060-018-2855-z/fulltext.html

Reference32 articles.

1. Chamberlain MC et al (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82(1):81–83

2. Fink J, Born D, Chamberlain MC (2011) Pseudoprogression: relevance with respect to treatment of high-grade gliomas. Curr Treat Options Oncol 12(3):240–252

3. Brandes AA et al (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26(13):2192–2197

4. Linhares P et al (2013) Early pseudoprogression following chemoradiotherapy in glioblastoma patients: the value of RANO evaluation. J Oncol 2013:690585

5. Young RJ et al (2013) MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clin Imaging 37(1):41–49

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinguishing glioblastoma progression from treatment-related changes using DTI directionality growth analysis;Neuroradiology;2024-08-17

2. A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors;EJNMMI Research;2024-02-02

3. Diagnosing pseudoprogression in glioblastoma: A challenging clinical issue;Neuro-Oncology Practice;2023-12-13

4. Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study;Neuro-Oncology Practice;2023-10-03

5. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model;Journal of Neuro-Oncology;2023-05